Medical Condition News

RSS

Primary care physicians' starring role key to weight loss, find Johns Hopkins researchers

A review of survey data from more than 300 obese people who participated in a federally funded weight loss clinical trial found that although the overall weight loss rates were modest, those who rated their primary care doctor's support as particularly helpful lost about twice as many pounds as those who didn't.

24 Aug 2015

UT System Board of Regents approves new UT Southwestern Monty and Tex Moncrief Medical Center

The University of Texas System Board of Regents has approved establishment of the UT Southwestern Monty and Tex Moncrief Medical Center at Fort Worth, made possible by an extraordinary $25 million commitment from W.A. "Tex" Moncrief Jr. The Center is UT Southwestern's first named campus outside of Dallas.

24 Aug 2015

Cognitive factors associated with activity, participation in everyday life among people with MS

Kessler Foundation researchers found that processing speed is the primary limiting factor associated with activity and participation in everyday life among people with multiple sclerosis (MS). "Factors that moderate activity limitation and participation restriction in people with multiple sclerosis" was published in the American Journal of Occupational Therapy.

24 Aug 2015

Poor sleep may impact treatment and recovery in veterans with PTSD, TBI

Poor sleep may impact treatment and recovery in veterans with Post-Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI). A review of extensive research on sleep in TBI and PTSD has found that sleep-focused interventions can improve treatment outcomes in veterans.

24 Aug 2015

Alpha lipoic acid can stimulate telomerase with positive effects in mouse model of atherosclerosis

In human cells, shortened telomeres, the protective caps at the ends of chromosomes, are both a sign of aging and contribute to it. Scientists at Emory University School of Medicine have found that the dietary supplement alpha lipoic acid (ALA) can stimulate telomerase, the enzyme that lengthens telomeres, with positive effects in a mouse model of atherosclerosis.

24 Aug 2015

Novel technique may lead to therapies for pain relief in individuals with intractable pain

A team of scientists at Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS) has developed a novel technique using tiny gold rods to target pain receptors.

24 Aug 2015

ARVO Foundation for Eye Research to present Dr. David L. Epstein Award at ARVO 2016

To honor the memory of a longtime leader in glaucoma treatment and research, the ARVO Foundation for Eye Research will present the Dr. David L. Epstein Award. The new award — a $100,000 prize — was established by the late Dr. Epstein's family and will be presented annually to a senior-level glaucoma researcher at the ARVO Annual Meeting.

24 Aug 2015

HPPI commences enrollment for Phase II(b) SCORING clinical trial for cancer treatment

HedgePath Pharmaceuticals, Inc., a clinical stage biopharmaceutical company that discovers, develops and plans to commercialize innovative therapeutics for patients with cancer, announced today enrollment has commenced in its Phase II(b) SCORING (SUBA-Cap Objective Response in Gorlin's) clinical trial.

23 Aug 2015

Berg and University of Miami extend partnership to battle cardiac dysfunction, heart failure

Berg, a Boston-based biopharmaceutical company, and the University of Miami Leonard M. Miller School of Medicine are extending its collaboration to battle cardiac dysfunction and heart failure. According to the American Heart Association, cardiovascular disease is the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030.

23 Aug 2015

NW Bio's DCVax-L Phase III trial ongoing for treatment of patients with newly diagnosed GBM

Northwest Biotherapeutics, a U.S. biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, confirmed today that its Phase III trial of DCVax-L for newly diagnosed glioblastoma multiforme (GBM) is ongoing and the patients enrolled in the trial are continuing to be treated per the protocol.

23 Aug 2015

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

MTG Biotherapeutics, an immuno-oncology company developing novel therapeutics for the treatment of cancer, today announced that the US Food and Drug Administration has granted Orphan Drug Designation for MTG-201, an advanced biologic therapy targeting Dickkopf-3 gene defects in various cancers, for the treatment of malignant mesothelioma.

23 Aug 2015

Number of dementia patients stabilizing experts claim

Risk of dementia may be falling due to improved education and living conditions, and better prevention and treatment of vascular diseases, highlighting the need for policies to improve health across the life course.

21 Aug 2015

Low rate of mortality from breast cancer after DCIS diagnosis

Research published this week estimates that the risk of dying from early stage breast cancer within 20 years of diagnosis is very low (3.3%).

21 Aug 2015

IQWiG dossier assessment finds added benefit of afatinib in patients with certain mutations

Afatinib (trade name: Giotrif) has been approved since September 2013 for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating EGF receptor mutations who have not been treated with an EGF receptor tyrosine-kinase inhibitor (EGFR TKI).

21 Aug 2015

Novel wound closure technique may reduce complication rates for patients with scoliosis

Patients with scoliosis who undergo surgery may be less likely to develop an infection or other complications after the procedure when a novel wound closure technique pioneered at NYU Langone Medical Center is utilized, according to new research.

21 Aug 2015

Loyola University Medical Center first in Illinois to offer new, noninvasive test for heart disease

Loyola University Medical Center is the first and only hospital in Illinois to offer a new, noninvasive technology to test for coronary artery disease.

21 Aug 2015

Study: Women warriors at no greater risk than men for developing PTSD

While past research on the question has been mixed, a new study by Defense and Veterans Affairs researchers suggests that women in the military are at no greater risk than men for developing posttraumatic stress disorder, given similar experiences--including combat.

21 Aug 2015

Two proteins that help cells eliminate trash may contribute to development of Parkinson's disease

Two proteins that share the ability to help cells deal with their trash appear to need each other to do their jobs and when they don't connect, it appears to contribute to development of Parkinson's disease, scientists report.

21 Aug 2015

Researchers establish structure of important tumor-suppressing protein

An international group of researchers led by Carnegie Mellon University physicists Mathias Lösche and Frank Heinrich have established the structure of an important tumor suppressing protein, PTEN. Their findings provide new insights into how the protein regulates cell growth and how mutations in the gene that encodes the protein can lead to cancer.

21 Aug 2015

Potential biomarker could help prevent pre-diabetic individuals from developing Type II diabetes

Virginia Tech researchers have identified a biomarker in pre-diabetic individuals that could help prevent them from developing Type II diabetes.

21 Aug 2015

Medical Condition News

Primary care physicians' starring role key to weight loss, find Johns Hopkins researchers

UT System Board of Regents approves new UT Southwestern Monty and Tex Moncrief Medical Center

Cognitive factors associated with activity, participation in everyday life among people with MS

Poor sleep may impact treatment and recovery in veterans with PTSD, TBI

Alpha lipoic acid can stimulate telomerase with positive effects in mouse model of atherosclerosis

Novel technique may lead to therapies for pain relief in individuals with intractable pain

ARVO Foundation for Eye Research to present Dr. David L. Epstein Award at ARVO 2016

HPPI commences enrollment for Phase II(b) SCORING clinical trial for cancer treatment

Berg and University of Miami extend partnership to battle cardiac dysfunction, heart failure

NW Bio's DCVax-L Phase III trial ongoing for treatment of patients with newly diagnosed GBM

MTG Biotherapeutics' MTG-201 granted FDA Orphan Drug Designation for malignant mesothelioma treatment

Number of dementia patients stabilizing experts claim

Low rate of mortality from breast cancer after DCIS diagnosis

IQWiG dossier assessment finds added benefit of afatinib in patients with certain mutations

Novel wound closure technique may reduce complication rates for patients with scoliosis

Loyola University Medical Center first in Illinois to offer new, noninvasive test for heart disease

Study: Women warriors at no greater risk than men for developing PTSD

Two proteins that help cells eliminate trash may contribute to development of Parkinson's disease

Researchers establish structure of important tumor-suppressing protein

Potential biomarker could help prevent pre-diabetic individuals from developing Type II diabetes

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News